1. Home
  2. FSBW vs TENX Comparison

FSBW vs TENX Comparison

Compare FSBW & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FS Bancorp Inc.

FSBW

FS Bancorp Inc.

HOLD

Current Price

$40.95

Market Cap

293.6M

Sector

Finance

ML Signal

HOLD

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$12.12

Market Cap

317.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSBW
TENX
Founded
1936
1967
Country
United States
United States
Employees
537
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
293.6M
317.8M
IPO Year
2011
2001

Fundamental Metrics

Financial Performance
Metric
FSBW
TENX
Price
$40.95
$12.12
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$46.00
$29.67
AVG Volume (30 Days)
10.6K
629.9K
Earning Date
04-21-2026
05-15-2026
Dividend Yield
2.79%
N/A
EPS Growth
N/A
N/A
EPS
1.02
N/A
Revenue
$4,612,000.00
N/A
Revenue This Year
$14.94
N/A
Revenue Next Year
$10.47
N/A
P/E Ratio
$40.29
N/A
Revenue Growth
44.80
N/A
52 Week Low
$36.72
$5.34
52 Week High
$44.22
$18.38

Technical Indicators

Market Signals
Indicator
FSBW
TENX
Relative Strength Index (RSI) 54.98 44.63
Support Level $40.79 $10.83
Resistance Level $40.97 $14.15
Average True Range (ATR) 0.80 0.73
MACD 0.01 0.05
Stochastic Oscillator 62.53 48.36

Price Performance

Historical Comparison
FSBW
TENX

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of First Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

Share on Social Networks: